ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
tubulis
A Lead Process Development Scientist at Tubulis is responsible for managing the entire lifecycle of linker-payloads, designing synthetic routes for small molecule products, supporting GMP manufacturing, and establishing a network of CMO partners to develop and optimize processes in accordance with regulatory requirements.
Tubulis is a Germany-based biotechnology company, now part of Gilead Sciences, focused on developing antibody–drug conjugates (ADCs) with proprietary platform technologies designed to expand the therapeutic potential of the drug class. Its growing pipeline includes clinical-stage ADC candidates TUB-040 (targeting NaPi2b) and TUB-030 (targeting 5T4), being evaluated in solid tumor indications including platinum-resistant ovarian cancer. Tubulis aims to advance innovative ADC design across its pipeline and in partnership with collaborators to benefit patients with high-need oncology indications.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for tubulis.
16% below the average for this role
Scientist Small Molecule SMDD
Eli Lilly and Company
Scientist - Small Molecule Technology
Pfizer
Process Development Scientist
Piramal Pharma Solutions
Principal Scientist, Analytical Development and QC, Small Molecule
immunomeinc
Analytical Sr Scientist
Amgen
Scientist - Small Molecule SMDD Foundry Readiness
Eli Lilly and Company